Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients

作者：Xi Chen, Liangjie Fang, Yan‐Ping Zhu, Zhang Bao, Qing Wang, Rong Liu, Wenjia Sun, Haiwei Du, Jing Lin, Bing Yu, Songan Chen, Jianya Zhou, Jianying Zhou, Jianying Zhou, Jianying Zhou · 发表于：Cancer Immunology Immunotherapy · 年份：2021 · DOI：10.1007/s00262-021-02943-2 · 被引用次数：45 · 研究领域：Cancer Immunotherapy and Biomarkers、Lung Cancer Treatments and Mutations、Cancer Genomics and Diagnostics